Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Showing 20 of 0 results

Not applicableStudy completedNCT00333710
What this trial is testing

Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD

Who this might be right for
Chronic DiseaseHepatitis CStress Disorders, Post-Traumatic
US Department of Veterans Affairs 53
Post-approval studies (Phase 4)Study completedNCT01439776
What this trial is testing

Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Hanyang University 180
Early research (Phase 1)Study completedNCT01740791
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 103
Testing effectiveness (Phase 2)Study completedNCT00115908
What this trial is testing

Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Human Genome Sciences Inc. 458
Not applicableUnknownNCT04208035
What this trial is testing

Hepatitis C Elimination in the Netherlands

Who this might be right for
Chronic Hepatitis c
Radboud University Medical Center 250
Large-scale testing (Phase 3)Study completedNCT02092350
What this trial is testing

Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)

Who this might be right for
Hepatitis C Virus
Merck Sharp & Dohme LLC 237
Large-scale testing (Phase 3)UnknownNCT00336518
What this trial is testing

Continuing Treatment With Pegasys and Copegus

Who this might be right for
Chronic Hepatitis C
Májbetegekért Alapítvány 100
Large-scale testing (Phase 3)Study completedNCT02282709
What this trial is testing

Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 12
Early research (Phase 1)Ended earlyNCT01651767
What this trial is testing

Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Who this might be right for
Chronic Hepatitis C Infection
Janssen R&D Ireland 11
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Early research (Phase 1)Study completedNCT00671671
What this trial is testing

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

Who this might be right for
Hepatitis, ChronicHepatitis C Virus
Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT00561353
What this trial is testing

TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec Pharmaceuticals, Ireland 121
Not applicableStudy completedNCT01402583
What this trial is testing

Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Prof. Facchinetti Fabio 1,000
Large-scale testing (Phase 3)WithdrawnNCT01608737
What this trial is testing

A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT00249860
What this trial is testing

Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

Who this might be right for
Hepatitis C
EMD Serono 257
Large-scale testing (Phase 3)Study completedNCT00781274
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 32
Early research (Phase 1)Study completedNCT01766167
What this trial is testing

Clinical Pharmacology Study of MP-424

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 26
Not applicableStudy completedNCT00705224
What this trial is testing

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus
Merck Sharp & Dohme LLC 250
Large-scale testing (Phase 3)Ended earlyNCT00662220
What this trial is testing

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 110
Large-scale testing (Phase 3)Study completedNCT00780910
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 109
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation